• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征、中东呼吸综合征和新型冠状病毒肺炎:临床、实验室及影像学特征概述与比较

SARS, MERS and CoVID-19: An overview and comparison of clinical, laboratory and radiological features.

作者信息

Pustake Manas, Tambolkar Isha, Giri Purushottam, Gandhi Charmi

机构信息

Department of Internal Medicine, Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai, India.

Department of Internal Medicine, BJ Government Medical College and Sassoon Hospital, Pune, India.

出版信息

J Family Med Prim Care. 2022 Jan;11(1):10-17. doi: 10.4103/jfmpc.jfmpc_839_21. Epub 2022 Jan 31.

DOI:10.4103/jfmpc.jfmpc_839_21
PMID:35309670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8930171/
Abstract

In the 21 century, we have seen a total of three outbreaks by members of the coronavirus family. Although the first two outbreaks did not result in a pandemic, the third and the latest outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) culminated in a pandemic. This pandemic has been extremely significant on a social and international level. As these viruses belong to the same family, they are closely related. Despite their numerous similarities, they have slight distinctions that render them distinct from one another. The Severe Acute Respiratory Distress Syndrome and Middle East Respiratory Syndrome (MERS) cases were reported to have a very high case fatality rate of 9.5 and 34.4% respectively. In contrast, the CoVID-19 has a case fatality rate of 2.13%. Also, there are no clear medical countermeasures for these coronaviruses yet. We can cross information gaps, including cultural weapons for fighting and controlling the spread of MERS-CoV and SARS-CoV-2, and plan efficient and comprehensive defensive lines against coronaviruses that might arise or reemerge in the future by gaining a deeper understanding of these coronaviruses and the illnesses caused by them. The review thoroughly summarises the state-of-the-art information and compares the biochemical properties of these deadly coronaviruses with the clinical characteristics, laboratory features and radiological manifestations of illnesses induced by them, with an emphasis on comparing and contrasting their similarities and differences.

摘要

在21世纪,我们总共目睹了冠状病毒家族成员引发的三次疫情。尽管前两次疫情并未导致全球大流行,但第三次也是最近一次的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫情最终演变成了一场大流行。这场大流行在社会和国际层面都具有极其重大的意义。由于这些病毒属于同一家族,它们密切相关。尽管它们有许多相似之处,但也存在一些细微的差别,使它们彼此不同。据报道,严重急性呼吸窘迫综合征和中东呼吸综合征(MERS)病例的病死率分别高达9.5%和34.4%。相比之下,新冠病毒的病死率为2.13%。此外,目前还没有针对这些冠状病毒的明确医疗对策。通过更深入地了解这些冠状病毒及其引发的疾病,我们可以跨越信息鸿沟,包括对抗和控制MERS-CoV和SARS-CoV-2传播的文化手段,并规划针对未来可能出现或再次出现的冠状病毒的高效、全面的防线。这篇综述全面总结了最新信息,并将这些致命冠状病毒的生化特性与它们引发疾病的临床特征、实验室特征和影像学表现进行了比较,重点是比较和对比它们的异同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bff/8930171/ee96a54d8ae4/JFMPC-11-10-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bff/8930171/ee96a54d8ae4/JFMPC-11-10-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bff/8930171/ee96a54d8ae4/JFMPC-11-10-g001.jpg

相似文献

1
SARS, MERS and CoVID-19: An overview and comparison of clinical, laboratory and radiological features.严重急性呼吸综合征、中东呼吸综合征和新型冠状病毒肺炎:临床、实验室及影像学特征概述与比较
J Family Med Prim Care. 2022 Jan;11(1):10-17. doi: 10.4103/jfmpc.jfmpc_839_21. Epub 2022 Jan 31.
2
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.从 SARS 和 MERS 到 COVID-19:三种高致病性人冠状病毒引起的严重急性呼吸道感染的简要总结和比较。
Respir Res. 2020 Aug 27;21(1):224. doi: 10.1186/s12931-020-01479-w.
3
Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far.严重急性呼吸综合征冠状病毒、中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2感染的经验教训:我们目前所了解的情况。
Can J Infect Dis Med Microbiol. 2022 Aug 12;2022:1156273. doi: 10.1155/2022/1156273. eCollection 2022.
4
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
5
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.新型冠状病毒表现的全面综述——在致命的 COVID-19 全球大流行背景下。
Am J Med Sci. 2020 Jul;360(1):5-34. doi: 10.1016/j.amjms.2020.05.006. Epub 2020 May 11.
6
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
7
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.阿贝尔森激酶抑制剂是严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒融合的强效抑制剂。
J Virol. 2016 Sep 12;90(19):8924-33. doi: 10.1128/JVI.01429-16. Print 2016 Oct 1.
8
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.SARS-CoV-2 传播的独特特征:与 SARS-CoV、MERS-CoV 和 2009 年 H1N1 大流行性流感病毒的比较。
Rev Med Virol. 2021 Mar;31(2):e2171. doi: 10.1002/rmv.2171. Epub 2020 Sep 18.
9
Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks.主要冠状病毒疫情的临床特征、诊断与治疗
Front Med (Lausanne). 2020 Nov 13;7:581521. doi: 10.3389/fmed.2020.581521. eCollection 2020.
10
From SARS coronavirus to novel animal and human coronaviruses.从严重急性呼吸综合征冠状病毒到新型动物和人类冠状病毒。
J Thorac Dis. 2013 Aug;5 Suppl 2(Suppl 2):S103-8. doi: 10.3978/j.issn.2072-1439.2013.06.02.

引用本文的文献

1
Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury.免疫调节:对抗SARS-CoV-2诱导的心肌损伤的关键。
Front Immunol. 2025 May 14;16:1561946. doi: 10.3389/fimmu.2025.1561946. eCollection 2025.
2
A label-free nanowell-based impedance sensor for ten-minute SARS-CoV-2 detection.一种用于十分钟内检测新型冠状病毒(SARS-CoV-2)的基于纳米孔的无标记阻抗传感器。
Sens Diagn. 2025 Apr 30. doi: 10.1039/d5sd00002e.
3
Epimaps of the SARS-CoV-2 Receptor-Binding Domain Mutational Landscape: Insights into Protein Stability, Epitope Prediction, and Antibody Binding.

本文引用的文献

1
Elevated cardiac biomarkers may be effective prognostic predictors for patients with COVID-19: A multicenter, observational study.心脏生物标志物升高可能是COVID-19患者有效的预后预测指标:一项多中心观察性研究。
Am J Emerg Med. 2021 Jan;39:34-41. doi: 10.1016/j.ajem.2020.10.013. Epub 2020 Oct 13.
2
Conceptions of the pathophysiology of happy hypoxemia in COVID-19.对 COVID-19 中快乐低氧血症的病理生理学的认识。
Respir Res. 2021 Jan 8;22(1):12. doi: 10.1186/s12931-021-01614-1.
3
Clinical characteristics and analysis of risk factors for disease progression of COVID-19: A retrospective Cohort Study.
严重急性呼吸综合征冠状病毒2受体结合域突变景观的表观图谱:对蛋白质稳定性、表位预测和抗体结合的见解
Biomolecules. 2025 Feb 18;15(2):301. doi: 10.3390/biom15020301.
4
AlphaFold2 Reveals Structural Patterns of Seasonal Haplotype Diversification in SARS-CoV-2 Nucleocapsid Protein Variants.AlphaFold2 揭示了 SARS-CoV-2 核衣壳蛋白变异株季节性单倍型多样化的结构模式。
Viruses. 2024 Aug 25;16(9):1358. doi: 10.3390/v16091358.
5
Future support on evidence-informed priority setting and situational analysis of the potential role of Health Technology Assessment in Africa to support future pandemic preparedness and response: protocol for a scoping review.未来对循证优先事项设定和非洲卫生技术评估潜在作用的情景分析的支持,以支持未来的大流行病防备和应对:范围综述方案。
Syst Rev. 2024 Jul 26;13(1):198. doi: 10.1186/s13643-024-02610-4.
6
Effect of Vaccination on Seroprevalence of COVID-19 among Blood donors - A cross-sectional Analytic Study from South India.接种疫苗对印度南部献血者中新冠病毒血清流行率的影响——一项横断面分析研究
Indian J Hematol Blood Transfus. 2024 Jul;40(3):443-447. doi: 10.1007/s12288-023-01716-4. Epub 2023 Dec 16.
7
A high-throughput response to the SARS-CoV-2 pandemic.高通量应对 SARS-CoV-2 大流行。
SLAS Discov. 2024 Jul;29(5):100160. doi: 10.1016/j.slasd.2024.100160. Epub 2024 May 16.
8
Lipid Nanoparticle-Based Inhibitors for SARS-CoV-2 Host Cell Infection.基于脂质纳米颗粒的 SARS-CoV-2 宿主细胞感染抑制剂。
Int J Nanomedicine. 2024 Mar 28;19:3087-3108. doi: 10.2147/IJN.S448005. eCollection 2024.
9
Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-Analysis.新冠康复后的短期和长期胸部CT表现:一项系统评价和荟萃分析
Diagnostics (Basel). 2024 Mar 14;14(6):621. doi: 10.3390/diagnostics14060621.
10
Inhibitory Efficacy of Main Components of on the Interaction between Spike Protein of SARS-CoV-2 and Human Angiotensin-Converting Enzyme II.对 2019 新型冠状病毒刺突蛋白与人血管紧张素转换酶 II 相互作用的抑制作用。
Int J Mol Sci. 2024 Mar 2;25(5):2935. doi: 10.3390/ijms25052935.
COVID-19 疾病进展的临床特征及危险因素分析:一项回顾性队列研究。
Int J Biol Sci. 2021 Jan 1;17(1):1-7. doi: 10.7150/ijbs.50654. eCollection 2021.
4
Chest Radiograph (CXR) Manifestations of the Novel Coronavirus Disease 2019 (COVID-19): A Mini-review.新型冠状病毒病 2019(COVID-19)的胸部 X 线表现:小型综述。
Curr Med Imaging. 2021;17(6):677-685. doi: 10.2174/1573405616666201231103312.
5
Infectivity of asymptomatic versus symptomatic COVID-19.无症状与有症状的新型冠状病毒肺炎的传染性
Lancet. 2021 Jan 9;397(10269):93-94. doi: 10.1016/S0140-6736(20)32651-9. Epub 2020 Dec 18.
6
Silent hypoxaemia in COVID-19 patients.新型冠状病毒肺炎患者的静默性低氧血症。
J Physiol. 2021 Feb;599(4):1057-1065. doi: 10.1113/JP280769. Epub 2021 Jan 4.
7
Long COVID-19-it's not over until?长期新冠——直到何时才算结束?
Clin Microbiol Infect. 2021 Apr;27(4):506-508. doi: 10.1016/j.cmi.2020.12.001. Epub 2020 Dec 11.
8
Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital.新型冠状病毒肺炎患者中的肺炎克雷伯菌感染:意大利一家医院的2个月回顾性分析
Int J Antimicrob Agents. 2021 Jan;57(1):106245. doi: 10.1016/j.ijantimicag.2020.106245. Epub 2020 Nov 27.
9
One year update on the COVID-19 pandemic: Where are we now?关于 COVID-19 大流行的一年更新:我们现在在哪里?
Acta Trop. 2021 Feb;214:105778. doi: 10.1016/j.actatropica.2020.105778. Epub 2020 Nov 28.
10
Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients.新型冠状病毒肺炎患者外周血白细胞分类计数的变化:一项 148 例患者的横断面研究。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2099-2102. doi: 10.1016/j.dsx.2020.10.029. Epub 2020 Nov 2.